BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2017
View Archived Issues
Phase II data support use of ridinilazole as treatment for CDI
Read More
Ligand reports topline results from phase II trial of LGD-6972
Read More
FDA gives rare pediatric disease designation to Global Blood Therapeutics' GBT-440
Read More
GLP-1R agonist reduces intracranial pressure in a rat model of hydrocephalus
Read More
Retrophin enters collaboration to find therapeutics for NGLY1 deficiency
Read More
Cocrystal Pharma enters drug discovery collaboration with HitGen and InterX
Read More
Insmed reports topline data from CONVERT study of ALIS
Read More
Eagle Pharmaceuticals evaluates neuroprotective effects of Ryanodex in rodents
Read More
FDA approves Dotarem for use in children under 2 years of age
Read More
FDA, EMA grant orphan drug designation to QRX-421 for Usher syndrome
Read More
Grant supports IBBR's development of multispecific antibody as therapeutic for HIV
Read More
Prodrug improves cell targeting of glutaminase antagonist for hematological malignancies
Read More
Pulmatrix receives award to support development of PUR-1900
Read More
MacroGenics advances two bispecific DART product candidates
Read More
MEI licenses rights to voruciclib from Presage
Read More
Adipolin identified as a biomarker of coronary artery disease
Read More
Eiger BioPharmaceuticals obtains FDA orphan drug designation for HDV treatment
Read More
BioNTech enters patent licensing agreement with Cellscript for modified mRNA technology
Read More
Farmar Licensing discloses novel recombinant beta2 glycoprotein 1 peptides
Read More
Enzyvant Therapeutics' RVT-802 awarded FDA rare pediatric disease designation
Read More
University of Primorska, Institute of Oncology Ljubljana patent IL-12 cancer gene therapy
Read More
U.S. Department of Health & Human Services creates new nucleic acids encoding arginase
Read More
Biocon partners with JDRF for Insulin Tregopil trial in type 1 diabetes
Read More
Novel antibacterial compounds identified at Redx Pharma
Read More
Chrysalis presents new lysine-specific demethylase 5B inhibitors
Read More
Bioverativ and Bicycle form research collaboration in hemophilia and sickle cell disease
Read More
Avadel enters license agreement for U.S. and Canadian rights to Noctiva
Read More
Ortho Dermatologics submits NDA for IDP-118 for plaque psoriasis
Read More
Janssen discovers prostanoid EP3 receptor antagonists with promising drug characteristics
Read More